UFC star Conor McGregor has claimed that a psychoactive Ibogaine treatment in Tijuana, Mexico, under the guidance of Stanford University doctors, saved his life and healed his brain. The treatment, which involves Ibogaine—a substance derived from plants—targets traumatic brain injuries, PTSD, anxiety, and depression. McGregor described the experience as ‘incredible, intense, and absolutely eye-opening,’ including visions of his death and a spiritual encounter with God.
McGregor, who recently accepted an 18-month suspension from the UFC following a doping policy violation, highlighted the treatment as a crucial turning point in his personal and professional life. He claimed that the Ibogaine therapy not only addressed his mental health struggles but also provided a profound spiritual awakening. The fighter emphasized the importance of the treatment in restoring his sense of self and reconnecting with his family. However, the medical community remains divided on the efficacy and safety of Ibogaine, citing potential risks such as cardiotoxicity and unpredictable psychological effects. While McGregor advocates for its use, the drug is not approved for medical use in the United States. His experience underscores the growing interest in alternative treatments for mental health challenges, particularly among high-profile athletes.
Stanford University researchers previously supported Ibogaine’s medical applications, noting its potential to reduce PTSD, anxiety, and depression in veterans with traumatic brain injuries. However, studies from the University of Virginia School of Medicine warn of the drug’s association with serious side effects, including heart damage. McGregor’s case highlights the intersection of sports, mental health, and the search for effective treatments, even in the face of regulatory and medical uncertainties. As he approaches his potential return to the UFC in 2026, his public endorsement of Ibogaine could influence ongoing discussions about its use in clinical settings.